Maintenance Guide · Updated November 2026

GLP-1 Maintenance Guide: What Happens When You Stop (2026)

In the STEP 1 extension, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year. In SURMOUNT-4, people switched from tirzepatide to placebo regained 14% of their body weight over the next 52 weeks, while those who stayed on the drug kept losing. The pattern is clear: stopping without a plan usually leads to significant regain. This guide covers the trial data, what the labels say about maintenance doses, and the habits worth building while you are still on treatment.

I am seven months into Mounjaro, down to 181.6 lbs and about 22% body fat (tracked with DEXA scans). I have not stopped yet. But the question of when and how to stop, or whether to move to a lower maintenance dose, is something I think about constantly. The data on weight regain after GLP-1 cessation is sobering. Pretending I will be the exception without a strategy would be reckless.

This is the broader context for anyone on a GLP-1 who is thinking about their long-term plan. If you want more on post-medication habits, read our GLP-1 exit strategy guide.

The Weight Regain Reality: What the Clinical Trials Show

STEP 1 extension (semaglutide 2.4 mg). Participants lost an average of 17.3% of body weight over 68 weeks. After stopping, they regained 11.6 percentage points by week 120, about two-thirds of what they had lost, for a net loss of 5.6% from the start. Most cardiometabolic improvements moved back toward baseline. The authors concluded that ongoing treatment is needed to maintain the improvements.

SURMOUNT-4 (tirzepatide). After a 36-week lead-in where participants lost an average of 20.9%, people were randomized to stay on tirzepatide or switch to placebo for 52 weeks. From week 36 to week 88, weight changed by -5.5% on tirzepatide versus +14.0% on placebo. By our rough math, the placebo group gave back about half of what it had lost.

SURMOUNT-5 is a different kind of trial. It was a 72-week head-to-head study, not a stopping or maintenance study. Adults without diabetes lost 20.2% on tirzepatide versus 13.7% on semaglutide at maximum tolerated doses.

Trial	Drug	Average loss on drug	What happened next
STEP 1 extension	Semaglutide 2.4 mg	17.3% at week 68	About two-thirds regained by week 120 after stopping
SURMOUNT-4	Tirzepatide	20.9% at week 36	Placebo group regained 14.0% of body weight over 52 weeks. Drug group lost another 5.5%
SURMOUNT-5	Tirzepatide vs semaglutide	20.2% vs 13.7% at week 72	Head-to-head comparison, no stopping phase

The message from the data is consistent: for most people, GLP-1 medications treat a chronic condition rather than providing a one-time fix.

Why People Stop GLP-1 Medications

Cost. Brand-name drugs are expensive without coverage. As of Nov 4, 2026, LillyDirect lists Zepbound self-pay from $299 to $449 a month with timely refills, and NovoCare lists the Wegovy pen at $349 a month. Those costs add up over years.

Side effects. Nausea, constipation, and fatigue are common. Some people stop because side effects do not settle. Our side effects guide covers what to expect.

Reaching goal weight. Some patients hit their target and assume the job is done. The trial data above shows why that is risky without a plan.

Pregnancy planning. The Wegovy label says to discontinue at least 2 months before a planned pregnancy because of semaglutide’s long half-life. The Zepbound label says to stop when pregnancy is recognized and warns that it may cause fetal harm. If you are planning a pregnancy, talk to your prescriber about timing.

Insurance changes. Job changes, plan changes, or prior authorization denials can cut off coverage.

What Happens to Your Body When You Stop

Semaglutide has a half-life of about 1 week and tirzepatide about 5 days, so the drug clears gradually over several weeks rather than all at once. Many people notice appetite returning in the weeks after their last dose.

The trials show that regain is not instant. In STEP 1, regain built over the year after stopping. Your body also burns somewhat less energy at a lower weight, which is one reason maintenance takes ongoing effort.

Maintenance Dosing vs. Full Stop

The honest answer from the data is that many people will need some form of ongoing treatment to keep their results. What that looks like is a decision for you and your prescriber.

What the labels say. The Zepbound label lists 5 mg, 10 mg, or 15 mg once weekly as maintenance doses for weight reduction and long-term maintenance. The 2.5 mg dose is the starting dose for the first 4 weeks. The Wegovy label lists 2.4 mg once weekly as the usual maintenance dose for the injection.

Continued treatment. This is what SURMOUNT-4 tested. People who stayed on tirzepatide kept the weight off better than those switched to placebo.

Lower doses or longer gaps. Some prescribers try lower doses for maintenance. Large trial data on this approach is limited, and doses below the label’s maintenance range are off-label. Do not split pens, stretch doses, or change your schedule on your own.

Compounded versions. Compounded GLP-1 drugs are not FDA approved, and custom “microdoses” from compounders have not been tested in large trials. Do not convert between compounded and brand doses without your prescriber.

Full stop. For some patients, stopping is the right choice. If you stop, plan it with your prescriber, track your weight, and agree in advance on what would make you restart or change course.

Looking for a GLP-1 provider?

See MEDVi Plans →

The “Runway” Concept: Building Habits While Still on Medication

I think of GLP-1 medication as a runway. The drug gives you a window where appetite is lower, cravings are manageable, and making good choices feels easier. The question is whether you use that window only to lose weight, or also to build the habits that help after you stop.

What to build during your medication runway:

Protein habits. Make protein a regular part of every meal. Ask your prescriber or a dietitian for a target that fits you, especially if you have kidney disease. Our muscle preservation protocol covers food sources.
Resistance training routine. Regular strength training helps preserve lean mass during weight loss.
Food awareness. Notice what true hunger feels like versus habitual or emotional eating. That awareness is useful after you stop.
Sleep routine. A consistent sleep schedule supports appetite control and energy.
Monitoring systems. Regular weigh-ins with a rolling average, and an agreed weight with your prescriber that would prompt a check-in.

Exercise and Diet for Maintenance

Resistance training. It helps preserve lean mass. Our muscle preservation protocol has the training split I follow.

Protein. Protein is filling, which helps when appetite returns. Your target depends on your size, health, and kidney function.

Calorie awareness. You do not need to count calories forever, but periodic tracking can help you notice drift.

Daily movement. Walking and other everyday activity add up and tend to drop after weight loss unless you keep them up.

The Cost of Staying On vs. Restarting

Staying on a brand-name drug costs the self-pay or insurance price every month. As of Nov 4, 2026, the lowest LillyDirect Zepbound price is $299 a month for 2.5 mg, but 2.5 mg is a starting dose, not a label maintenance dose. The label maintenance doses (5 mg and up) list at $399 to $449 a month with timely refills. Stopping and restarting means paying again to re-titrate, often with side effects returning at the start. Run your own numbers with your plan’s coverage, and talk to your prescriber about what is medically right before cost.

For pricing by provider, see our cheapest GLP-1 online guide and provider directory.

When Is It Reasonable to Consider Stopping?

There are no validated criteria. Points worth discussing with your prescriber:

Your weight has been stable for a while on a steady dose.
Your habits feel routine, not forced.
You have a monitoring plan and agreed signals for restarting.
Your emotional relationship with food has been addressed if it was a factor. A therapist or counselor can help.
You have medical follow-up after stopping.
You are not heading into a major stress period, such as a move or job change.

My Personal Approach: The Taper Plan

I have not started tapering yet. I am still working toward my goal of 165 lbs at 13-15% body fat. My current dose is 7.5 mg tirzepatide. My rough idea is to reach and hold my goal, then talk with my prescriber about stepping down gradually while watching my weight trend, and to stay on whatever dose keeps me stable if appetite and weight creep back.

Note that 2.5 mg is the label’s starting dose, not a maintenance dose, so any plan that goes below 5 mg is off-label. This is my personal plan to discuss with my prescriber, not a protocol to copy. Do not change your dose without your prescriber.

Provider Options for Long-Term Treatment

What to ask your provider:

How do you handle patients who reach their goal weight?
What is your monitoring plan for patients in maintenance?
If I stop and need to restart, how quickly can I get back on medication?

LillyDirect and NovoCare: Both manufacturer programs sell brand-name drugs directly. As of Nov 4, 2026, LillyDirect lists Zepbound vials and KwikPens from $299 a month, and NovoCare lists the Wegovy pill from $149 a month and the pen at $349 a month.

FAQ

How much weight do you regain after stopping Ozempic or Mounjaro?

In the STEP 1 extension, people regained about two-thirds of the weight lost within one year of stopping semaglutide 2.4 mg. In SURMOUNT-4, people switched from tirzepatide to placebo regained 14% of body weight over 52 weeks. Individual results vary.

Can you stay on a low dose of Mounjaro forever?

The Zepbound label lists 5 mg, 10 mg, and 15 mg as maintenance doses for long-term weight maintenance. Mounjaro is approved for type 2 diabetes, and 2.5 mg is a starting dose on both labels. Long-term use below the label maintenance range has not been tested in large trials. Discuss long-term dosing with your prescriber.

What is the cheapest way to stay on a GLP-1?

It depends on your coverage. As of Nov 4, 2026, brand self-pay prices start at $149 a month for the Wegovy pill and $299 a month for Zepbound 2.5 mg, with higher prices for maintenance doses. See our cheapest GLP-1 guide.

How long does it take for appetite to come back after stopping a GLP-1?

It varies. Semaglutide has a half-life of about one week and tirzepatide about five days, so the drug clears over several weeks. Many people notice appetite returning in that period.

Is GLP-1 weight loss permanent if you build good habits?

Some people keep the weight off after stopping, but in the trials most regained a significant portion. Habits improve your odds but do not guarantee it. Plan long-term treatment with your prescriber.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. ClearMetabolic may earn a commission through provider links on this page. See our full disclosure.

Guides:

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Tools: GLP-1 Cost Estimator · Body Composition Calculator

Compare: All Providers · Best GLP-1 Programs · All Guides

What we checked

This AI-assisted public-source desk check reviewed the STEP 1 extension and SURMOUNT-4 abstracts on PubMed, the SURMOUNT-5 publication in NEJM, the Wegovy and Zepbound prescribing information, the FDA page on unapproved GLP-1 drugs, and LillyDirect and NovoCare price pages on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.